- $729.57m
- $764.37m
- $216.39m
- 46
- 29
- 47
- 35
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 106 | 111 | 147 | 181 | 216 |
Cost of Revenue | |||||
Gross Profit | 87.4 | 85.9 | 119 | 149 | 173 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 104 | 105 | 158 | 243 | 259 |
Operating Profit | 2.72 | 5.82 | -10.8 | -62 | -42.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.97 | 5.03 | -13 | -67.4 | -47.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.12 | 3.5 | -13.7 | -67.3 | -47.8 |
Net Income Before Extraordinary Items | |||||
Net Income | 3.12 | 3.5 | -13.7 | -67.3 | -47.8 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.12 | 2.69 | -13.7 | -67.3 | -47.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.041 | 0.035 | -0.172 | -0.642 | -0.541 |
Dividends per Share |